Clinical Trials Directory

Trials / Terminated

TerminatedNCT00622570

Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension

Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension.

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Hospital Universitari Son Dureta · Academic / Other
Sex
All
Age
15 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Objective: to assess the effectiveness of pentobarbital and thiopental to control raised intracranial pressure (ICP), refractory to first level measures, in patients with severe traumatic brain injury. Material and methods: prospective, randomized open study to compare the effectiveness between two treatments: pentobarbital and thiopental. The patients will be selected from those admitted to the Intensive Care Unit with a severe traumatic brain injury (postresuscitation Glasgow Coma Scale equal or less than 8 points) and raised ICP (ICP\>20 mmHg) refractory to first level measures according to the Brain Trauma Foundation guidelines. The adverse effects of both treatments were also collected.

Conditions

Interventions

TypeNameDescription
DRUGPentobarbital10 mg/kg in 30 minutes; then 5 mg/kg/h during 3 hours; then 1 mg/kg/h
DRUGthiopental2 mg/kg in bolus; if ICP is not below 20 mmHg then 3 mg/kg in bolus; if ICP is not below 20 mmHg it can be administrated a third bolus of 5 mg/kg. Maintenance: 3 mg/kg/h in perfusion

Timeline

Start date
2002-05-01
Primary completion
2007-07-01
Completion
2007-12-01
First posted
2008-02-25
Last updated
2008-02-25

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00622570. Inclusion in this directory is not an endorsement.